Loading...
Analysts' Top Stock Picks: Buy Auro Pharma, NALCO, Ajanta Pharma; Sell IndusInd Bank
LIVE TV
LOCAL
Tour
ENGLISH
For You
Entertainment
National
Sports
Markets
Business & Economy
Lifestyle
World
Astrology & Religion
Technology
Education & Jobs
Auto
Politics
Viral
Opinions
Loading more articles...
Home
Local
Live TV
Analysts Recommend Buy: Auro Pharma, NALCO, Ajanta Pharma; Sell: IndusInd Bank
C
CNBC TV18
•
11-03-2026, 12:44
Analysts Recommend Buy: Auro Pharma, NALCO, Ajanta Pharma; Sell: IndusInd Bank
•
Market experts suggest buy/sell opportunities based on technical and derivative indicators.
•
Ajit Mishra of Religare Broking recommends buying Aurobindo Pharma with a target of ₹1,450 and stop loss at ₹1,250.
•
Mishra also advises selling IndusInd Bank with a target of ₹838 and stop loss at ₹910.
•
Ashish Kyal of Waves Strategy Advisors suggests buying National Aluminium Company (NALCO) with a target of ₹425 and stop loss at ₹390.
•
Kyal also recommends buying Ajanta Pharma with a target of ₹3,240 and stop loss at ₹2,980.
Read Full Article on Cnbc in English
✦
More like this
✦
More like this
Analysts Advise: Buy DRL, Auro Pharma; Sell Kalyan Jewellers, PG Electroplast, GMR Airports
C
CNBC TV18
Tech Analysts Recommend Buys: Vedanta, NALCO, Apollo Hospitals, NTPC; Sells: RVNL, Dabur
C
CNBC TV18
Top Analysts Recommend Buy Calls on PNB, L&T, HDFC Life, and More Stocks
C
CNBC TV18
Sudeep Shah Recommends Glenmark Pharma, Schaeffler India: Buy Now!
C
CNBC TV18
Analysts Advise Buy Coal India, BEL; Sell JSW Energy, Indigo, Indian Hotels, Godrej Consumer
C
CNBC TV18
Short Sell Alert: PFC, SAIL, ICICI Bank, Axis Bank, Ashok Leyland on Analysts' Radar
C
CNBC TV18
